Fig. 1From: Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemiaPARP inhibition reduced the cell viability of primary CML cells. CML P#1 and P#2 cells were incubated with indicated concentration of PARP inhibitor talazoparib for 48 h. Cell viability was detected by CCK-8 assay. (N = 3, mean ± SD, **P < 0.01)Back to article page